Anti-cMet SIMPLE Antibody

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAnti-cMet SIMPLE Antibody
Drug Alias NameARGX-111
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionHepatocyte growth factor receptor inhibitorsAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsImmunomodulators
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesArgenx Se
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArgenx Se
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A